Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. - Weinblatt,M.E.; Keystone,E.C.; Furst,D.E. (Arthritis Rheum, 2003)